摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(4-ethoxy-3-methoxy-phenethyl)-formamide | 857789-78-7

中文名称
——
中文别名
——
英文名称
N-(4-ethoxy-3-methoxy-phenethyl)-formamide
英文别名
Ameisensaeure-(3-methoxy-4-aethoxy-β-phenaethylamid);N-(4-Aethoxy-3-methoxy-phenaethyl)-formamid;N-Formyl-O-aethyl-homovanillylamin;N-[2-(4-ethoxy-3-methoxyphenyl)ethyl]formamide
<i>N</i>-(4-ethoxy-3-methoxy-phenethyl)-formamide化学式
CAS
857789-78-7
化学式
C12H17NO3
mdl
——
分子量
223.272
InChiKey
SKOKCAXATWIUMP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    16
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.42
  • 拓扑面积:
    47.6
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-(4-ethoxy-3-methoxy-phenethyl)-formamide甲苯三氯氧磷 作用下, 生成 7-ethoxy-6-methoxy-3,4-dihydroisoquinoline
    参考文献:
    名称:
    Kondo; Tanaka, Yakugaku Zasshi/Journal of the Pharmaceutical Society of Japan, 1929, vol. 49, p. 4
    摘要:
    DOI:
  • 作为产物:
    参考文献:
    名称:
    Synthesis and antihypertensive activity of a series of spiro[1,3,4,6,7,11b-hexahydro-2H-benzo[a]quinolizine-2,5'-oxazolidin-2'-one]s
    摘要:
    The 2R*,11bS* and 2S*,11bS* diastereoisomers of the spiro[1,3,4,6,7,11b-hexahydro-2H-benzo[a]quinolizine-2, 5'-oxazolidin-2'-one] system were prepared by stereoselective methods. Evaluation of these compounds for antihypertensive activity by oral administration to the spontaneously hypertensive rat showed the 2S*,11bS* series was the more potent. Within that series it was found that small alkyl substituents at positions 3 and 4' enhanced antihypertensive activity and that methoxyl substitution at positions 9 and 10 was optimal. (2S,3S,11bS)-Spiro-[2-ethyl-9,10-dimethoxy-1,3,4,6,7, 11b-hexahydro-2H-benzo[a]quinolizine-2,5'-oxazolidin-2'-one] [(-)-9e] was one of the most efficacious compounds of this series, while its antipode, (+)-9e, was inactive. Selected compounds in this series were shown to be alpha-adrenoceptor antagonists.
    DOI:
    10.1021/jm00364a013
点击查看最新优质反应信息

文献信息

  • Spaeth; Dobrowsky, Chemische Berichte, 1925, vol. 58, p. 1281
    作者:Spaeth、Dobrowsky
    DOI:——
    日期:——
  • Kondo; Tanaka, Yakugaku Zasshi/Journal of the Pharmaceutical Society of Japan, 1929, vol. 49, p. 4
    作者:Kondo、Tanaka
    DOI:——
    日期:——
  • Synthesis and antihypertensive activity of a series of spiro[1,3,4,6,7,11b-hexahydro-2H-benzo[a]quinolizine-2,5'-oxazolidin-2'-one]s
    作者:Joan M. Caroon、Robin D. Clark、Arthur F. Kluge、Chi Ho Lee、Arthur M. Strosberg
    DOI:10.1021/jm00364a013
    日期:1983.10
    The 2R*,11bS* and 2S*,11bS* diastereoisomers of the spiro[1,3,4,6,7,11b-hexahydro-2H-benzo[a]quinolizine-2, 5'-oxazolidin-2'-one] system were prepared by stereoselective methods. Evaluation of these compounds for antihypertensive activity by oral administration to the spontaneously hypertensive rat showed the 2S*,11bS* series was the more potent. Within that series it was found that small alkyl substituents at positions 3 and 4' enhanced antihypertensive activity and that methoxyl substitution at positions 9 and 10 was optimal. (2S,3S,11bS)-Spiro-[2-ethyl-9,10-dimethoxy-1,3,4,6,7, 11b-hexahydro-2H-benzo[a]quinolizine-2,5'-oxazolidin-2'-one] [(-)-9e] was one of the most efficacious compounds of this series, while its antipode, (+)-9e, was inactive. Selected compounds in this series were shown to be alpha-adrenoceptor antagonists.
查看更多